TickerGuard
Buy Day today: Neutral (45) Mixed market breadth · no major macro event
VXRT

Vaxart Inc

Healthcare · Biotechnology

0.355$ -1.4% vs. previous close Closing price · As of: Nov 17, 2026

Statements

Income Statement

Vaxart Inc (VXRT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 11 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VXRT
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 LTM
3.2 2.2 6.4 4.9 15 21 40 72 104 39 27 11 181
1.2 1.1 1.1 – 1.1 – – – 23 – – 1.3 –
2.0 2.2 6.4 4.9 15 21 40 72 104 39 27 9.3 180
15 19 17 15 23 31 50 76 45 29 34 23 131
5.4 7.2 5.2 4.3 4.0 5.1 4.6 4.3 3.7 4.6 6.6 5.1 20
19 26 23 19 27 36 54 80 49 34 40 27 150
-17 -24 -16 -14 -11 -15 -15 -7.8 55 5.2 -13 -17 30
0.9 0.8 0.6 0.6 0.9 1.0 0.7 0.6 0.5 0.5 0.5 0.6 2.2
-17 -24 -16 -14 -12 -15 -15 -8.1 55 5.2 -13 -17 30
0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.7
-17 -24 -16 -14 -12 -16 -15 -8.1 55 5.2 -13 -18 29
-15 -21 -14 -11 -8.6 -12 -12 -5.4 58 6.8 -12 -16 37

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?